A5051067217- Systemic Sclerosis and Related Diseases
- Inflammatory Myopathies and Dermatomyositis
- Systemic Lupus Erythematosus Research
- Dermatological and Skeletal Disorders
- Autoimmune and Inflammatory Disorders Research
- Bone and Joint Diseases
- Bone health and treatments
- Immunodeficiency and Autoimmune Disorders
- Eosinophilic Disorders and Syndromes
- Lymphoma Diagnosis and Treatment
- Spondyloarthritis Studies and Treatments
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Monoclonal and Polyclonal Antibodies Research
- Musculoskeletal synovial abnormalities and treatments
- Skin Diseases and Diabetes
- Bone Tumor Diagnosis and Treatments
- Chronic Lymphocytic Leukemia Research
- Rheumatoid Arthritis Research and Therapies
- Sarcoidosis and Beryllium Toxicity Research
- Peripheral Neuropathies and Disorders
- Osteomyelitis and Bone Disorders Research
- Adolescent and Pediatric Healthcare
- Bone health and osteoporosis research
- Orthopedic Surgery and Rehabilitation
- Hematological disorders and diagnostics
Hospital Universitario Ramón y Cajal
2012-2023
Hospital Universitario de Guadalajara
2020-2021
Instituto Ramón y Cajal de Investigación Sanitaria
2019-2020
Center for Rheumatology
2013-2018
Instituto Cajal
2014-2018
Madrid Health Service
2017
National University of Distance Education
2016
Instituto Nacional de Salud del Niño
2016
Marathon Veterinary Hospital
2015
Jabil (United States)
2015
Objectives To determine the causes of death and risk factors in systemic sclerosis (SSc). Methods Between 2000 2011, we examined certificates all French patients with SSc to death. Then developed a score associated all-cause mortality from international European Scleroderma Trials Research (EUSTAR) database. Candidate prognostic were tested by Cox proportional hazards regression model single variable analysis, followed multiple stratified centres. The bootstrapping technique was used for...
Antisynthetase syndrome (ASSD) is a rare clinical condition that characterized by the occurrence of classic triad, encompassing myositis, arthritis, and interstitial lung disease (ILD), along with specific autoantibodies are addressed to different aminoacyl tRNA synthetases (ARS). Until now, it has been unknown whether presence ARS might affect presentation, evolution, outcome ASSD. In this study, we retrospectively recorded time onset, characteristics, clustering triad findings, survival...
Anti Jo-1 antibodies are the main markers of antisynthetase syndrome (ASSD), an autoimmune disease clinically characterized by occurrence arthritis, myositis, and interstitial lung (ILD). These manifestations usually co-occur (for practical purpose complete forms) in same patient, but cases with only 1 or 2 these findings incomplete have been described. In forms, ex novo further is possible, although frequencies timing not still defined. The aim this international, multicenter, retrospective...
Adult-onset Still's disease (AOSD) is frequently refractory to standard therapy. Tocilizumab (TCZ) has demonstrated efficacy in single cases and small series of patients with AOSD. The aim this multicenter study was assess the TCZ AOSD conventional treatment.This a retrospective open-label treatment 34 who had experienced an inadequate response corticosteroids at least 1 synthetic immunosuppressive drug also, many cases, biologic agents.The mean ± SD age (8 men 26 women) 38.7 16.1 years....
Adult-onset Still's disease (AOSD) is often refractory to standard therapy. Anakinra (ANK), an interleukin-1 receptor antagonist, has demonstrated efficacy in single cases and small series of AOSD. We assessed the ANK a AOSD patients. Multicenter retrospective open-label study. was used due lack synthetic immunosuppressive drugs some also at least 1 biologic agent. Forty-one patients (26 women/15 men) were recruited. They had mean age 34.4 ± 14 years median [interquartile range (IQR)]...
Objectives: Juvenile systemic sclerosis is a rare childhood disease. Three disease activity indices have been published for adult patients with sclerosis: the European Scleroderma Study Group Index, modified version of Index and revised Trials Research index. The objective this study was to determine feasibility performance three in prospectively followed cohort juvenile sclerosis. Methods: analysis selected from prospective international inception enrolling patients. correlation physicians’...